Target Price | $1.79 |
Price | $0.76 |
Potential |
134.87%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Nautilus Biotechnology 2026 .
The average Nautilus Biotechnology target price is $1.79.
This is
134.87%
register free of charge
$2.63
245.39%
register free of charge
$1.01
32.89%
register free of charge
|
|
A rating was issued by 9 analysts: 7 Analysts recommend Nautilus Biotechnology to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nautilus Biotechnology stock has an average upside potential 2026 of
134.87%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.56 | -0.61 |
9.80% | 8.93% | |
P/E | negative |
5 Analysts have issued a Nautilus Biotechnology forecast for earnings per share. The average Nautilus Biotechnology EPS is
This results in the following potential growth metrics and future valuations:
Nautilus Biotechnology...
Analyst | Rating | Action | Date |
---|---|---|---|
Goldman Sachs |
Locked
➜
Locked
|
Locked | Dec 05 2024 |
Analyst Rating | Date |
---|---|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Dec 05 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.